Brain Death Reversed With Stem Cells
Stem cells have the potentialto be used to treat and better understand some of the worldsmost deadly and disabling diseases.
The Big Q: Who is not interested in new ways to apply stem celltherapy?
The Big A:We are and have opened our Tatget 150 clinic in Bangkok,Thailand to apply this growing, life extending science.
We have recently heard about scientists in Philadelphia, PA,USA who have been injecting stem cells directly into the spinalcords of medically brain-dead people in order to revive them.
The idea of bringing people back from the dead is alittle too much for some critics to manage.
In March 2017, researchers at the biotechcompany,Bioquark,gotapproval to begin a clinical trial with 20 test patients to seeif neural brain damage could be reversed.
TheBioquarkwebsitesays the research and development organization is a lifesciences company developing proprietary combinatorial biologicproducts for both the regeneration and repair of human organsand tissues, as well as the reversion of a range of chronicdegenerative diseases.
Integrating regenerative biology, evolutionary genomics, andbio-cybernetics, the futurists are offering death-resistingtreatments: a set of novel bio-products capable of directlyremodeling diseased, damaged, or aged tissues.
These achievements alone sound compelling, Yes?
But, then when adding the potential of restoring brain functionto a lifeless mind and the appeal goes up, way up.
Bioquarkgotthe federal nod t go ahead with their Non-randomized,Open-labeled, Interventional, Single Group, Proof of ConceptStudy With Multi-modality Approach in Cases of Brain Death Dueto Traumatic Brain Injury Having Diffuse Axonal Injury study,slated to begin in July 2018. Youll note theres no mention ofraising the dead at this point.
The study participants will not be injected with stem cells.that is just the 1st step of this experimental treatment. Next,a peptide formula will be injected into the spinal cord. Thisis supposed to help new neurons grow. Finally, a 15-day courseof nerve stimulation and laser therapy will be administered, tostimulate neurons to form connections.
The main diagnostic tool is the electroencephalogram (EEG)which measures brainwaves and records them for future review.EEG results will be used to determine if the therapy is workingor not.
Diffuse axonal injury (DAI) is a type of traumatic braininjury. It happens when the brain suddenly and swiftly shiftsinside the skull while an injury is happening. The axons (longconnecting fibers) in the brain are sheared when the brainsmacks against the skull and bounces back, accelerating anddecelerating rapidly.
DAI commonly damages many parts of the brain, to the extentthat DAI patients are typically in a coma state. The mainsymptom is loss of consciousness, which usually lasts no morethan six hours or so. But even if a person comes out of acomatose state, there may be signs of brain damage such as:
This multi-pronged treatment that combines injections of stemcells and chemical formulas with nerve stimulation is brand newand already attracting controversy.
Some of the debate has nothing to do with morality or ethics,but talk about the way to sign up a study participant who hasbeen pronounced legally dead.
Most US state laws define death as the irreversible loss ofheart and lung or brain function.
The Big Qs 2&3: If the researchers are successful inrestoring brainwaves to an inactive mind, will the patientspersonality and memories be restored intact? Will theindividual be in a mental condition comparable to what theperson had before the traumatic brain injury?
The Big As 2&3:
Dr. Ed Cooper, an orthopedic surgeon involved in the study,gave Zero odds for success because the procedure must act on afunctional brain stem which connects most of the motor neuronsto the cerebral cortex.
But Ira Pastor, Bioquarks CEO, agreed with his colleague, Dr.Cooper in principle but gave hope for a positive outcomebecause there is a small nest of cells that continue tooperate in brain-dead patients.
Dr. Pastor is an optimist about restoring brain activity incomatose or brain-damaged patients. I just think its a matterof putting it all together and getting the right people and theright minds on it, he said.
Dr. Charles Cox, a pediatric surgeon at the University of TexasHealth Science Center atHouston who has researched the kind of stem cells used in theBioquark trial, echoed Dr. Coopers reservations: I thinkreviving someone would technically be a miracle. I think thePope would technically call that a miracle.
Eat healthy, Be healthy, Live lively
brain, cells, dead,injury, loss,miracle, neurons, patients, Pope,restoring, reversed, stem,study
Paul A. Ebeling, polymath, excels in diverse fields ofknowledge. Pattern Recognition Analyst in Equities,Commodities and Foreign Exchange and author of The RedRoadmasters Technical Report on the US Major MarketIndices, a highly regarded, weekly financial marketletter, he is also a philosopher, issuing insights on awide range of subjects to a following of over 250,000cohorts. An international audience of opinion makers,business leaders, and global organizations recognizesEbeling as an expert.
See the rest here:
Brain Death Reversed with Stem Cells - Emex Investment
- Breast Cancer Is Most Common Cancer In India, 1.38 Million Cases Diagnosed Annually. Know Estimated Incidence By 2030 - ABP Live - November 26th, 2023
- What Is Amyloidosis? All About The Rare Disease That Pervez Musharraf Suffered From - ABP Live - February 8th, 2023
- Autophagic death of neural stem cells mediates chronic stress-induced ... - November 7th, 2022
- Programmed cell death - Wikipedia - November 7th, 2022
- Hematopoietic Stem Cells | Hematopoiesis | Properties & Functions - September 4th, 2022
- Canadian Blood Services Stem Cells for Life - September 4th, 2022
- Devastation over death of schoolgirl, 11, who hoped she was beating cancer - Leicestershire Live - September 4th, 2022
- From optimized stem cell transplants to CAR T cell therapy: Advancing options for cancer, HIV and more - City of Hope - September 4th, 2022
- Scientists unlock the key to immortality in jellyfish - Syfy - September 4th, 2022
- Forge Biologics Reports Positive Clinical Data on Brain Development and Motor Function from the RESKUE Novel Phase 1/2 Gene Therapy Trial in Patients... - September 4th, 2022
- Menin Inhibitors Have Potential to Become the Next Class of Targeted Therapy in AML - Targeted Oncology - September 4th, 2022
- Wanted murder suspect John Belfield believed to still be in the UK as two more arrested over death of Thomas Campbell - The Manc - September 4th, 2022
- Next-day manufacture of a novel anti-CD19 CAR-T therapy for B-cell acute lymphoblastic leukemia: first-in-human clinical study | Blood Cancer Journal... - July 8th, 2022
- Can minds persist when they are cut off from the world? - Livescience.com - July 8th, 2022
- Black Adolescent Young Adults With AML Have Worse Outcomes Vs White Population - Cancer Network - July 8th, 2022
- Akari Therapeutics Announces First Patient to Complete Course of Treatment in the Phase III Part A Clinical Trial of Investigational Nomacopan in... - July 8th, 2022
- How abortion ruling could affect IVF and embryonic research - The Almanac Online - July 8th, 2022
- This Morning viewers 'in tears' after boy meets donor who saved his life - Devon Live - July 8th, 2022
- Alpena detective: 'Good people out there' | News, Sports, Jobs - Alpena News - July 8th, 2022
- 'I miss my best friend': Five-year-old runs 10k to honour girl who died from rare brain tumour - Teesside Live - July 8th, 2022
- Humanigen Announces Peer-Reviewed Publication in Thorax Supporting Early Treatment of Hospitalized COVID-19 Patients with Lenzilumab Guided by... - July 8th, 2022
- Novartis AG, AstraZeneca Plc, and Pfizer Inc Among Leading Companies in the Thyroid Cancer Pipeline Products Market | Globaldata Plc - Yahoo Finance - July 8th, 2022
- A New Strategy Could Turn the Tide in Stem Cell GVHD - Medical Device and Diagnostics Industry - January 17th, 2022
- Vertex type 1 diabetes vs stem cell therapy - The Boar - January 17th, 2022
- Two-Year OS Doubles for Patients With Philadelphia-Positive Relapsed ALL After HSCT - AJMC.com Managed Markets Network - January 17th, 2022
- Nowakowski Considers CD19 Therapy in Transplant-Ineligible DLBCL - Targeted Oncology - January 17th, 2022
- Psaki demolishes Doocy with stats as he tries to claim covid now an illness of the vaccinated - newsconcerns - January 17th, 2022
- Doctors and Researchers Probe How COVID-19 Attacks the Heart - The Scientist - January 17th, 2022
- Who does donated blood that's direly needed help? - WTOP - January 17th, 2022
- Places Where Omicron is Most Contagious Eat This Not That - Eat This, Not That - January 17th, 2022
- UHN and U of T receive $24-million federal grant for transplant research - News@UofT - January 17th, 2022
- Glycyrrhizic acid ameliorates submandibular gland oxidative stress, autophagy and vascular dysfunction in rat model of type 1 diabetes | Scientific... - January 17th, 2022
- Stem cells in cancer therapy: opportunities and challenges - January 1st, 2022
- Life After Brain Death: Is the Body Still 'Alive'? | Live ... - January 1st, 2022
- Autologous Adult Stem Cells in the Treatment of Stroke | SCCAA - Dove Medical Press - January 1st, 2022
- Stem Cell Mimicking Nanoencapsulation for Targeting Arthrit | IJN - Dove Medical Press - January 1st, 2022
- Cellular Therapies Fill Unmet Needs in R/R Multiple Myeloma - Targeted Oncology - January 1st, 2022
- Upregulated expression of actin-like 6A is a risk factor | CMAR - Dove Medical Press - January 1st, 2022
- COVID-19 Takes a Toll on People with Blood Cancers and Disorders - Cancer Health Treatment News - January 1st, 2022
- Mental health disorders and heart diseases - Rising Kashmir - January 1st, 2022
- Research breakthrough could mean better treatment for patients with most deadly form of brain tumor - EurekAlert - October 26th, 2021
- European Commission Approves Merck's KEYTRUDA (pembrolizumab) Plus Chemotherapy as Treatment for Certain Patients With Locally Recurrent Unresectable... - October 26th, 2021
- European Commission Selects Humanigen's Lenzilumab as One of the 10 Most Promising Treatments for COVID-19 - Galveston County Daily News - October 26th, 2021
- Everything You Need To Know About COVID Booster Shots - Colorado Times Recorder - October 26th, 2021
- Stem cells and their role in lung transplant rejection - Michigan Medicine - October 5th, 2021
- Losing Your Hair? You Might Blame the Great Stem Cell Escape. - The New York Times - October 5th, 2021
- Will humans ever be immortal? - Livescience.com - October 5th, 2021
- Healthcare Researchers Are Putting HUMAN Immune Systems In Pigs To Study Illnesses-Here's The Tech Behind It - Tech Times - October 5th, 2021
- Why Bezos, Musk, Page and other billionaires want to live forever - New York Post - October 5th, 2021
- Faster healing of wounds can decrease pain and suffering and save lives - ABC 12 News - October 5th, 2021
- U.S. FDA Approves Kite's Tecartus as the First and Only Car T for Adults With Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia - Business... - October 5th, 2021
- Skeletons' broken clavicles tell a centuries-old tale of humans and horses - Massive Science - October 5th, 2021
- Environmental Factor - August 2021: Extramural Papers of the Month - Environmental Factor Newsletter - August 4th, 2021
- Role of traumatic brain injury in the development of glioma | JIR - Dove Medical Press - August 4th, 2021
- Targeted Therapeutics Market: Increase in Incidence of Cancer to Drive Global Market - BioSpace - August 4th, 2021
- Accumulation of Regulatory T Cells in Triple Negative Breast Cancer Ca | CMAR - Dove Medical Press - August 4th, 2021
- Novel CAR-T Cell Therapy Produces Early and Deep Responses in Certain Patients with Multiple Myeloma - Curetoday.com - June 7th, 2021
- Autophagy suppresses the formation of hepatocyte-derived cancer-initiating ductular progenitor cells in the liver - Science Advances - June 7th, 2021
- Cancer research: New advances and innovations - Medical News Today - June 7th, 2021
- Fulvestrant Alone Found to be Superior to Venetoclax/Fulvestrant Combo in ER+/HER2- Breast Cancer - Targeted Oncology - June 7th, 2021
- Merck's KEYTRUDA Given After Surgery Reduced the Risk of Disease Recurrence or Death by 32% Versus Placebo as Adjuvant Therapy in Patients With Renal... - June 7th, 2021
- Stem cell study illuminates the cause of an inherited heart disorder | Penn Today - Penn Today - February 14th, 2021
- The race to treat a rare, fatal syndrome may help others with common disorders like diabetes - Science Magazine - February 14th, 2021
- Jasper Therapeutics Announces Positive Data from Phase 1 Clinical Trial of JSP191 as Targeted Stem Cell Conditioning Agent in Patients with... - February 14th, 2021
- The Very First Signs of an Immune Response Have Been Filmed in a Developing Embryo - ScienceAlert - February 14th, 2021
- Arlo's Army needs stem cell donor as mum begs for help to save three-year-old's life - Glasgow Live - February 14th, 2021
- Astellas and Seagen Announce Phase 3 Trial Results Demonstrating Survival Advantage of PADCEV (enfortumab vedotin-ejfv) in Patients with Previously... - February 14th, 2021
- [Full text] Successful Use of Nivolumab in a Patient with Head and Neck Cancer Aft | OTT - Dove Medical Press - February 14th, 2021
- The drug treatments offering the best hope of a way out of the Covid crisis - Telegraph.co.uk - February 14th, 2021
- In the war against Covid, an arsenal of drugs is on the way - Telegraph.co.uk - February 14th, 2021
- Kat Wests husband, Jeff West, sentenced to 16 years in wifes death - AL.com - February 9th, 2021
- Harnessing the Potential of Cell and Gene Therapy - OncLive - February 9th, 2021
- I Survived Cancer, and Then I Needed to Remember How to Live - The Atlantic - February 9th, 2021
- [Full text] Higher Red Blood Cell Distribution Width is a Poor Prognostic Factor f | CMAR - Dove Medical Press - February 9th, 2021
- West Belfast woman to be remembered in special TV documentary - Belfast Live - January 29th, 2021
- UTV documentary tells of young Belfast woman's lasting legacy to promote stem cell donation - The Irish News - January 29th, 2021
- L-MIND Trial Results Show CD19 Antibody Is Reasonable in R/R DLBCL - Targeted Oncology - January 29th, 2021
- Vertex Announces FDA Clearance of Investigational New Drug (IND) Application for VX-880, a Novel Cell Therapy for the Treatment of Type 1 Diabetes... - January 29th, 2021
- If I Have Cancer, Dementia or MS, Should I Get the Covid Vaccine? - Kaiser Health News - January 29th, 2021
- Experimental taphonomy of organelles and the fossil record of early eukaryote evolution - Science Advances - January 29th, 2021